These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors. Skrenkova K; Hemelikova K; Kolcheva M; Kortus S; Kaniakova M; Krausova B; Horak M Sci Rep; 2019 Aug; 9(1):12303. PubMed ID: 31444392 [TBL] [Abstract][Full Text] [Related]
6. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors. Mesic I; Madry C; Geider K; Bernhard M; Betz H; Laube B Neuropharmacology; 2016 Jun; 105():133-141. PubMed ID: 26777280 [TBL] [Abstract][Full Text] [Related]
7. Control of aversion by glycine-gated GluN1/GluN3A NMDA receptors in the adult medial habenula. Otsu Y; Darcq E; Pietrajtis K; Mátyás F; Schwartz E; Bessaih T; Abi Gerges S; Rousseau CV; Grand T; Dieudonné S; Paoletti P; Acsády L; Agulhon C; Kieffer BL; Diana MA Science; 2019 Oct; 366(6462):250-254. PubMed ID: 31601771 [TBL] [Abstract][Full Text] [Related]
15. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation. Langer K; Müller-Längle A; Wempe J; Laube B Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899 [TBL] [Abstract][Full Text] [Related]
16. Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells. Epping L; Schroeter CB; Nelke C; Bock S; Gola L; Ritter N; Herrmann AM; Räuber S; Henes A; Wasser B; Fernandez-Orth J; Neuhaus W; Bittner S; Budde T; Platten M; Kovac S; Seebohm G; Ruck T; Cerina M; Meuth SG Cell Mol Life Sci; 2022 Aug; 79(9):479. PubMed ID: 35951110 [TBL] [Abstract][Full Text] [Related]
17. Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases. Olivero G; Vergassola M; Cisani F; Usai C; Pittaluga A Mol Neurobiol; 2019 Sep; 56(9):6142-6155. PubMed ID: 30734226 [TBL] [Abstract][Full Text] [Related]
18. GluN2A Subunit-Containing NMDA Receptors Are the Preferential Neuronal Targets of Homocysteine. Sibarov DA; Abushik PA; Giniatullin R; Antonov SM Front Cell Neurosci; 2016; 10():246. PubMed ID: 27847466 [TBL] [Abstract][Full Text] [Related]
19. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors. Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313 [TBL] [Abstract][Full Text] [Related]
20. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation. Martínez-Turrillas R; Puerta E; Chowdhury D; Marco S; Watanabe M; Aguirre N; Pérez-Otaño I Neurobiol Dis; 2012 Dec; 48(3):290-8. PubMed ID: 22801082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]